The Truth About Mounjaro Side Effects on Your Skin

Mounjaro side effects deserve a clear, factual explanation before you start tirzepatide. This article explains the known risks, newer skin findings including dWAT depletion, and what you can do next.

Important: Riverbanks Clinic does not prescribe or supply Mounjaro or any GLP-1 agonist. We are a doctor-led medical aesthetics centre in Harpenden serving St Albans and Luton. We help patients manage dermatological changes such as laxity, deflation and dullness after rapid or medication-related weight loss.

Mounjaro side effects TL;DR

• Mounjaro is tirzepatide, a GLP-1 and GIP receptor agonist for type 2 diabetes.
• Common effects include nausea, diarrhoea, constipation and vomiting.
• Serious risks include pancreatitis, gallbladder disease and rare allergic reactions.
• Skin changes occur due to rapid fat loss and dWAT depletion. dWAT means dermal white adipose tissue.
• Riverbanks does not offer Mounjaro. We treat the visible skin consequences safely and ethically.

Who is this guide for

This guide is for adults considering tirzepatide, and for anyone already using it who wants a simple, evidence based summary of Mounjaro side effects. It is educational. It is not a substitute for personalised medical advice.

What Mounjaro is and how it works

Mounjaro is the brand name for tirzepatide. As a result, it activates GLP-1 and GIP receptors and helps regulate appetite. As a result, it reduces appetite and improves blood glucose control. It is licensed for type 2 diabetes. Some patients use it off label for weight loss under medical supervision.

Common Mounjaro side effects you may notice

Gastrointestinal symptoms are most frequent, particularly during dose increases. However, they often settle with time.

• Nausea
• Diarrhoea
• Constipation
• Vomiting
• Indigestion, bloating or abdominal pain

Tip: Smaller meals, slower eating, low fat foods and steady hydration can help. Speak to your prescriber if symptoms persist or worsen.

Serious risks that need urgent review

Pancreatitis

Seek emergency help if you develop severe abdominal pain, especially if it radiates to the back, with nausea or vomiting.

Gallbladder disease

Rapid weight loss can increase the risk of gallstones and gallbladder inflammation. Consequently, patients should report any persistent abdominal pain or fever.

Thyroid considerations

Animal studies showed thyroid C-cell tumours. Human relevance remains uncertain. Do not use if you have MEN2 or a personal or family history of medullary thyroid carcinoma.

Hypoglycaemia

Low blood sugar is more likely if combined with insulin or sulfonylureas. Know the signs. Monitor glucose closely.

Kidney injury and dehydration

Persistent vomiting or diarrhoea can cause dehydration and acute kidney injury. Maintain fluid intake. Seek help if you cannot keep fluids down.

Retinopathy changes

In diabetes, rapid glucose improvements can temporarily worsen retinopathy. Arrange regular eye checks when indicated.

Allergic reactions

Stop treatment and seek urgent care if you develop facial swelling, wheeze, widespread hives or faintness.

New science: why skin can look older on GLP-1 and GIP drugs

Many patients report sagging, hollowing and a tired look after medication related weight loss. Indeed, new scientific evidence may suggest why this occurs. Historically, we blamed subcutaneous fat loss alone. However, new research highlights a possible new mechanism.

dWAT depletion may explain disproportionate sagging

The dermal white adipose tissue, known as dWAT, is a distinct fat layer inside the dermis. It supports elasticity and dermal homeostasis. Recent work by Dr Sabrina Fabi suggests that GLP-1 and GIP therapies may deplete this layer. Consequently, skin loses scaffolding even when total fat loss seems modest.

• Mid face hollowing and under eye shadows
• Looser jawline and neck
• Crepey texture and fine lines
• Duller tone with reduced bounce

This mechanism sits alongside general volume loss. Together, they explain why some faces look prematurely aged after weight change.

Riverbanks Clinic’s position

• We do not prescribe or sell Mounjaro or other GLP-1 drugs.
• We treat dermatological effects such as laxity, deflation and dullness.
• We use doctor led, evidence based protocols with clinical supervision.

Treatment options we may recommend

Plans are individual. Furthermore, we focus on restoring structure and radiance while keeping results natural.

Sculptra

A biostimulatory injectable that encourages new collagen formation. It improves firmness and contour gradually.

Ellansé

A collagen stimulator that supports deep dermal architecture. It is useful for jawline support and lower face strength.

Secret RF microneedling

Radiofrequency microneedling targets dermal layers. It boosts collagen and elastin. It can improve thinning linked to dWAT loss.

Cool Laser

Fractional Er:YAG resurfacing refreshes texture and glow with measured downtime. It supports ongoing collagen remodelling.

Polynucleotides and exosomes

These regenerative options support fibroblast activity and barrier recovery. They enhance hydration and tone.

Explore related services during a consultation tailored to your goals.

Practical skin habits during treatment

• Use daily sunscreen and avoid midday sun.
• Prioritise protein to support dermal repair.
• Stay hydrated. Moreover, sip water regularly through the day to support skin elasticity.
• Avoid crash dieting that accelerates laxity.
• Consider staged weight loss to help the skin adapt.

Safety checklist before you start tirzepatide

• Discuss benefits and risks with your GP or endocrinologist.
• Review pancreas, gallbladder, kidney and thyroid history.
• Arrange baseline bloods if your prescriber advises them.
• Agree a plan for dose increases and side effect monitoring.
• Avoid unregulated or compounded products from unknown sources.

Key facts to remember about Mounjaro side effects

• Common effects are mostly gastrointestinal and often ease with time. Overall, most patients tolerate the medication well under supervision.
• Serious symptoms require urgent medical review.
• Skin changes arise from fat loss and dWAT depletion.
• Riverbanks does not offer Mounjaro. We treat the skin impact.

References

1. U.S. Food and Drug Administration. Tirzepatide (Mounjaro) Prescribing Information. 2022. FDA label
2. Drucker DJ et al. Mechanisms of GLP-1 receptor agonists. Nat Rev Drug Discov. 2021;20:611-628. Article
3. Fabi SG et al. Decoding the Implications of Glucagon-like Peptide-1 Receptor Agonists on Accelerated Facial and Skin Aging. Aesthetic Surgery Journal Open Forum. 2024.
4. Weiner JD et al. Aesthetic implications of GLP-1 weight loss. Aesthetic Surg J. 2023;43(10):NP605-NP611. Article

Ready to talk about your skin

We do not prescribe Mounjaro. We can assess and treat skin laxity, deflation and dullness with safe, doctor led care in Harpenden, St Albans and Luton.

Book a consultation or call 01582 762877. You can also download our Riverbanks app.

Last clinically reviewed: June 2026.

Subscribe to the blog

Get the latest articles sent straight to your inbox

First Name *

Last Name *

Email *

Phone Number

Where did you hear about us? *

Please select oneAdvertismentAnother ClientConferenceFacebookGooglePressRadioWebinar

I have read and agree to the privacy policy *

YES

 

Submit